Skip to content

Pharmacological activity of the basic fraction of marihuana whole smoke condensate alone and in combination with delta-9-tetrahydrocannabinol in mice.

J M Johnson, L Lemberger, M Novotny, R B Forney, W S Dalton, M P Maskarinec

Toxicology and Applied Pharmacology March 15, 1984 DOI: 10.1016/0041-008x(84)90120-0 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Animal pharmacology study Peer reviewed
Population Male Swiss-Webster mice
Intervention delta-9-tetrahydrocannabinol (THC)
Dose 5, 10, and 20 mg/kg (general screen); 10 to 29 mg/kg (second study); 1.2, 2.4, and 4.8 mg/kg BF with 1.0 mg/kg THC (temperature study)
Duration Body temperature measured periodically for 2 hr after administration
Topics Cannabis
Key points The basic fraction of marijuana whole smoke condensate produced slight, statistically significant but not consistently dose-dependent behavioral and autonomic effects in mice, including impaired visual placing, increased tail pinch response, reduced tail elevation, piloerection, and at higher doses reduced locomotion, rearing, and urination. It did not alter body temperature or THC-induced hypothermia. The authors conclude the fraction has some pharmacological activity but little evidence of highly active compounds.

Abstract

This basic fraction (BF) of marihuana whole smoke condensate was subjected to pharmacological testing in males, Swiss-Webster mice. In a general pharmacological activity screen looking at behavioral, neurologic, and autonomic parameters, BF, at iv doses of 5, 10, and 20 mg/kg, caused impairment of visual placing, increase in tail pinch response, decrease in tail elevation, and induction of piloerection. These effects, although statistically significant, were slight and not consistently dose dependent. In a second study with doses ranging from 10 to 29 mg/kg, BF caused a decrease in spatial locomotion, rearing behavior, and urination incidence. In a third study, body temperatures of mice were measured periodically for 2 hr following administration of BF (1.2, 2.4, and 4.8 mg/kg) alone or in combination with 1.0 mg/kg delta-9-tetrahydrocannabinol (THC). BF did not alter body temperature, nor did it affect THC-induced hypothermia. These results, although suggesting that the basic fraction of marihuana whole smoke condensate has pharmacological activity in mice, offers little evidence for the presence of highly active compounds.

Comparable studies

Other preclinical and animal studies on cannabis, most cited first.

Study Year Design Participants
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors Mice 2015 Preclinical study
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). hMDR1- and hBCRP-transfected HEK293 cells and hMDR1- and hBCRP-MDCKII cells 2010 In vitro study
Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure Mice prenatally exposed to THC, including conditional CB1R knockout mice 2020 Animal experimental study
Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway Mice exposed to chronic THC early in life 2018 Animal experimental study
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain Spontaneously hypertensive rats (SHRs) and Wistar rats 2014 Animal experimental study

Explore topics